Epigenomics (DE:ECX)
FRANKFURT:ECX
Germany Market
Advertisement

Epigenomics (ECX) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Neutral
11Bullish
1Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Epigenomics’s (ECX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Epigenomics is a Buy.
Epigenomics’s (ECX) 20-Day exponential moving average is 0.91, while Epigenomics’s (ECX) share price is €0.9, making it a Sell.
Epigenomics’s (ECX) 50-Day exponential moving average is 0.90, while Epigenomics’s (ECX) share price is €0.9, making it a Buy.

Epigenomics (ECX) Pivot Points

Nov 13, 2025, 10:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.87
0.88
0.88
0.89
0.89
0.90
0.90
Fibonacci
0.88
0.88
0.88
0.89
0.89
0.89
0.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Epigenomics (ECX) Moving Averages

Nov 13, 2025, 10:25 PM
Period
Simple
Exponential
MA5
0.89Buy
0.90Sell
MA10
0.93Sell
0.91Sell
MA20
0.90Sell
0.91Sell
MA50
0.89Buy
0.90Buy
MA100
0.86Buy
0.90Buy
MA200
0.92Sell
0.97Sell
Epigenomics’s (ECX) 10-Day exponential moving average is 0.91, while Epigenomics’s (ECX) share price is €0.9, making it a Sell.
Epigenomics’s (ECX) 100-Day exponential moving average is 0.90, while Epigenomics’s (ECX) share price is €0.9, making it a Buy.
Epigenomics’s (ECX) stock price is €0.9 and Epigenomics’s (ECX) 50-day simple moving average is 0.89, creating a Buy signal.
Epigenomics’s (ECX) stock price is €0.9 and Epigenomics’s (ECX) 100-day simple moving average is 0.86, creating a Buy signal.
Epigenomics’s (ECX) stock price is €0.9 and Epigenomics’s (ECX) 200-day simple moving average is 0.92, creating a Sell signal.

Epigenomics (ECX) Technical Indicators

Nov 13, 2025, 10:25 PM
Name
Value
Implied Action
RSI (14)
49.58
Neutral
STOCH (9,6)
4.31
Buy
STOCHRSI (14)
4.31
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
86.38
Sell
Williams %R
-96.10
Buy
CCI (14)
263.00
Sell
ATR (14)
0.11
-
Ultimate Oscillator
28.82
Sell
ROC
2.27
Buy
Epigenomics’s (ECX) Relative Strength Index (RSI) is 49.58, creating a Neutral signal.
Epigenomics’s (ECX) Trend Strength Indicator (ADX) is 86.38, creating a Sell signal.
Epigenomics’s (ECX) Commodity Channel Index (CCI) is 263.00, creating a Sell signal.
Epigenomics’s (ECX) Price Rate of Change (ROC) is 2.27, creating a Buy signal.

FAQ

Is ECX a Buy, Hold, or Sell?
Based on ECX’s technical indicators, ECX is a Hold.
    What is ECX’s RSI (14)?
    ECX’s RSI (14) is 49.58, which suggests ECX is a Neutral.
      What is ECX’s MACD?
      ECX’s MACD is <0.01, which suggests ECX is a Buy.
        What is ECX’s 5-day moving average?
        ECX’s 5-day moving average is 0.89, which suggests ECX is a Buy.
          What is ECX’s 20-day moving average?
          ECX 20-day moving average is 0.90, which suggests ECX is a Sell.
            What is ECX’s 50-day moving average?
            ECX’s 50-day moving average is 0.89, which suggests ECX is a Buy.
              What is ECX’s 200-day moving average?
              ECX’s 200-day moving average is 0.92, which suggests ECX is a Sell.
                What is ECX’s Williams % R (14)?
                ECX’s Williams % R (14) is -96.10, which suggests ECX is a Buy.
                  What is ECX’s CCI (14)?
                  ECX’s CCI (14) is 263.00, which suggests ECX is a Sell.
                    What is the share price of Epigenomics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis